Immune thrombocytopenia (ITP): vizsgálatok itt: Kína
67 trials · From ClinicalTrials.gov, checked 2026. november 13.. Ask the study team whether a trial fits you.
- 2. fázisNot yet taking people in KínaPhase II Study of Orelabrutinib in Combination With Romiplostim N01 in Patients With Primary Immune Thrombocytopenia (ITP) Who Have Received At Least One Prior Line of Therapy
- Where
- Beijing
- Életkor
- 18 év to 80 év
- People
- 28
- Run by
- Peking Union Medical College Hospital
See details and how to joinNCT07400250 - 2. fázisTaking peopleAnti-CD38 Monoclonal Antibody Combined With Rituximab in the Management of Primary Immune Thrombocytopenia (ITP)
- Where
- Tianjin
- Életkor
- 18 év and over
- People
- 20
- Run by
- Institute of Hematology & Blood Diseases Hospital, China
See details and how to joinNCT07362199 - 2. fázisTaking peopleDaratumumab Versus Rituximab in the Management of Pediatric Primary Immune Thrombocytopenia (ITP)
- Where
- Tianjin
- Életkor
- 6 év to 18 év
- People
- 122
- Run by
- Institute of Hematology & Blood Diseases Hospital, China
See details and how to joinNCT07362238 - 2. fázisTaking peopleA Study of DZD8586 in Adults With Primary Immune Thrombocytopenia (ITP) (TAI-SHAN11)
- Where
- Jinan
- Életkor
- 18 év and over
- People
- 60
- Run by
- Dizal Pharmaceuticals
See details and how to joinNCT07294365 - No phaseNot yet taking people in KínaA Study of CD19 UCAR-T Cells in Subjects With Autoimmune Diseases
- Where
- Tianjin
- Életkor
- 18 év to 65 év
- People
- 24
- Run by
- Institute of Hematology & Blood Diseases Hospital, China
See details and how to joinNCT07212322 - 1/2. fázisTaking peopleA Study of CM336 in Patients With Relapsed or Refractory Autoimmune Cytopenia
- Where
- Changzhi, Tianjin, Zhengzhou
- Életkor
- 18 év and over
- People
- 158
- Run by
- Keymed Biosciences Co.Ltd
See details and how to joinNCT07175493 - No phaseTaking peopleEfficacy and Safety of Romiplostim N01 Combined With Rituximab in Patients With Oral TPO-RA-Refractory Primary Immune Thrombocytopenia
- Where
- Suzhou
- Életkor
- 14 év and over
- People
- 30
- Run by
- The First Affiliated Hospital of Soochow University
See details and how to joinNCT07206823 - 2. fázisTaking peopleAnti-CD38 Antibody Treating Pediatric Primary Immune Thrombocytopenia (ITP)
- Where
- Tianjin
- Életkor
- 6 év to 17 év
- People
- 60
- Run by
- Institute of Hematology & Blood Diseases Hospital, China
See details and how to joinNCT06168851 - Korai 1. fázisTaking peopleSafety and Efficacy of PRG-1801 in Recurrent/Refractory Primary Immune Thrombocytopenia (ITP)
- Where
- Wuhan
- Életkor
- 18 év and over
- People
- 6
- Run by
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
See details and how to joinNCT06519565 - 1/2. fázisNot yet taking people in KínaAn Exploratory Study of Golidocitinib in Adult Patients With ITP
- Where
- Beijing
- Életkor
- 18 év to 80 év
- People
- 138
- Run by
- Peking University People's Hospital
See details and how to joinNCT07196163 - 4. fázisNot yet taking people in KínaSequential rhTPO and Eltrombopag Following Glucocorticoids for Severe Adult ITP
- Where
- Wuhan
- Életkor
- 12 év to 75 év
- People
- 150
- Run by
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
See details and how to joinNCT07189910 - Korai 1. fázisTaking peopleSafety Study of CC312 in Autoimmune Disease Patients
- Where
- Tianjin
- Életkor
- 18 év and over
- People
- 18
- Run by
- CytoCares Inc
See details and how to joinNCT06888960 - 2. fázisTaking peopleThe Efficacy and Safety of Combined Teriflunomide and High-dose Dexamethasone in Newly Diagnosed Primary Immune Thrombocytopenia (TEMPO-2)
- Where
- Beijing
- Életkor
- 18 év and over
- People
- 132
- Run by
- Peking University People's Hospital
See details and how to joinNCT07065968 - No phaseTaking peopleAnti CD19/BCMA CAR Gene Therapy for Relapsed/Refractory Immune Thrombocytopenia
- Where
- Changsha
- Életkor
- 18 év and over
- People
- 18
- Run by
- Anhui Provincial Hospital
See details and how to joinNCT06973356 - 1. fázisTaking peopleInaticabtagene Autoleucel Injection in the Treatment of Refractory Systemic Lupus Erythematosus-related Immune Thrombocytopenia
- Where
- Beijing
- Életkor
- 18 év to 70 év
- People
- 12
- Run by
- Juventas Cell Therapy Ltd.
See details and how to joinNCT06826430 - 1/2. fázisTaking peopleA Clinical Study of NAD in the Treatment of Immune Thrombocytopenia
- Where
- Tianjin
- Életkor
- 18 év and over
- People
- 20
- Run by
- Institute of Hematology & Blood Diseases Hospital, China
See details and how to joinNCT06776510 - 2. fázisTaking peopleAnti-CD38 Antibody Treating Children With Primary Immune Thrombocytopenia (ITP)
- Where
- Tianjin
- Életkor
- 6 év to 18 év
- People
- 30
- Run by
- Institute of Hematology & Blood Diseases Hospital, China
See details and how to joinNCT06838962 - 2. fázisNot yet taking people in KínaA Study on the Safety and Efficacy of TQB3473 Tablets in the Treatment of Persistent or Chronic Primary Immune Thrombocytopenia (ITP) in Adults
- Where
- Anyang, Baoding, Beijing, Changchun, Changsha, Changzhi, Chengde, Chongqing, Ganzhou, Guangzhou, Guiyang, Haikou, Hangzhou, Harbin, Hefei, Jinan, Kunming, Lanzhou, Linyi, Nanchang, Nanjing, Nanning, Nantong, Nanyang, Ningbo, Shanghai, Shenyang, Shenzhen, Shijiazhuang, Taiyuan, Tangshan, Tianjin, Ürümqi, Wuhan, Wuhu, Xi'an, Xi’an, Xining, Yantai, Zhanjiang, Zhengzhou
- Életkor
- 18 év and over
- People
- 320
- Run by
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
See details and how to joinNCT07083739 - No phaseNot yet taking people in KínaLongitudinal Observational Study on Immune Thrombocytopenia
- Where
- Beijing
- People
- 2000
- Run by
- Peking University People's Hospital
See details and how to joinNCT07068425 - 2. fázisNot yet taking people in KínaThe Combination of Upadacitinib and High-dose Dexamethasone as First-line Treatment in Adult Immune Thrombocytopenia
- Where
- Beijing
- Életkor
- 18 év to 70 év
- People
- 132
- Run by
- Peking University People's Hospital
See details and how to joinNCT07064889 - 2. fázisTaking peopleAnti-CD38 Antibody Treating Elderly Patients With Primary Immune Thrombocytopenia (ITP)
- Where
- Tianjin
- Életkor
- 60 év and over
- People
- 30
- Run by
- Institute of Hematology & Blood Diseases Hospital, China
See details and how to joinNCT07063199 - 2. fázisNot yet taking people in KínaIguratimod Plus Low-dose Rituximab vs Low-dose Rituximab in Corticosteroid-resistant or Relapsed ITP
- Where
- Beijing
- Életkor
- 18 év to 70 év
- People
- 120
- Run by
- Peking University People's Hospital
See details and how to joinNCT07057778 - 1/2. fázisTaking peopleA Dose-escalation Study Followed by a Dose Optimal Study to Evaluate the Safety and Efficacy of CID-103 in Adults With Chronic Immune Thrombocytopenia
- Where
- Jinan, Kunming, Nanchang, Tangshan, Tianjin, Zhengzhou
- Életkor
- 18 év to 65 év
- People
- 75
- Run by
- CASI pharmaceuticals, Inc.
See details and how to joinNCT07017725 - 2. fázisTaking peopleRomiplostim N01 Combined With Glucocorticoids as the First-line Treatment for Newly Diagnosed Adult Primary Immune Thrombocytopenia: A Multicenter, Interventional Trial
- Where
- Tianjin
- Életkor
- 18 év to 75 év
- People
- 129
- Run by
- Institute of Hematology & Blood Diseases Hospital, China
See details and how to joinNCT06992128 - 3. fázisTaking peopleA Study of TQB3473 Tablets Compared to Placebo in the Treatment of Adult Primary Immune Thrombocytopenia
- Where
- Anyang, Baoding, Beijing, Changchun, Changsha, Changzhi, Chengde, Chongqing, Ganzhou, Guangzhou, Guiyang, Haikou, Hangzhou, Harbin, Hefei, Jinan, Kunming, Lanzhou, Linyi, Nanchang, Nanjing, Nanning, Nantong, Nanyang, Ningbo, Shanghai, Shenyang, Shenzhen, Shijiazhuang, Taiyuan, Tangshan, Tianjin, Ürümqi, Wuhan, Wuhu, Xi'an, Xi’an, Xining, Xuchang, Yangzhou, Yantai, Zhanjiang, Zhengzhou
- Életkor
- 18 év to 75 év
- People
- 199
- Run by
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
See details and how to joinNCT06900920